Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLASS Canadian Left Atrial Appendage Closure Study

NCT03133806 is registered in ClinicalTrials.gov with Cardia Inc. as lead sponsor.

NCT NCT03133806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03133806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLASS Canadian Left Atrial Appendage Closure Study
Lead sponsor
Cardia Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2017
Completion date
August 15, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left atrial appendage, non-valvular atrial fibrillation